Diabetic Ketoacidosis (DKA) Overview

Overview and Pathophysiology of Diabetic Ketoacidosis (DKA)

  • Definition: Diabetic Ketoacidosis (DKA) is a life-threatening complication of diabetes characterized by three primary clinical features:
    • Uncontrolled hyperglycemia.
    • Metabolic acidosis.
    • Increased production of ketones.
  • Physiological Mechanisms:
    • DKA is often triggered by profound dehydration. For example, a patient who has been vomiting for several days or has been out in the sun sweating excessively loses a significant amount of fluid volume, leading to a state of profound dehydration.
    • The presence of ketones in the urine is a hallmark indicator of the body breaking down fat for fuel in the absence of adequate insulin.
    • Drug Interactions: The combination of being diabetic and taking corticosteroids is a known trigger for DKA, as corticosteroids lead to increased blood sugar levels.

Prevalence and Precipitating Factors

  • Primary Populations:
    • Type 1 Diabetes: DKA occurs most often in patients with Type 1 diabetes. It is frequently seen in individuals who were previously undiagnosed and did not know they were diabetic until the onset of DKA.
    • Type 2 Diabetes: While less common, DKA can occur in Type 2 diabetic patients under conditions of severe physiological stress. Examples of such stress include trauma, infection, or major surgery.
  • Precipitating Factors:
    • The most common factor that precipitates an episode of DKA is infection.
    • Other factors include severe dehydration from environmental heat or illness (vomiting).

Clinical Manifestations and Symptoms

  • Classic Signs and Symptoms:
    • Polyuria: Excessive urination.
    • Polydipsia: Excessive thirst.
    • Polyphagia: Excessive hunger.
    • Weight Loss: Unintentional weight loss often accompanying the onset of symptoms.
    • Gastrointestinal Distress: Includes vomiting and significant abdominal pain.
    • Dehydration: Resulting from fluid loss and osmotic diuresis.
    • Weakness: Generalized physical fatigue.
    • Altered Mental Status (AMS): Changes in consciousness or cognitive function due to metabolic imbalances.

Laboratory Findings and Diagnostic Criteria

  • Glucose: Blood glucose levels are typically greater than 250mg/dL250\,mg/dL.
  • Arterial pH: Evidence of metabolic acidosis with a pH of less than 7.357.35.
  • Bicarbonate (HCO3HCO_3): Levels will be less than 21mEq/L21\,mEq/L.
  • Serum Sodium (NaNa): Levels may vary and can present as low, normal, or high.
  • Kidney Function Markers:
    • BUN (Blood Urea Nitrogen): Elevated levels greater than 30mg/dL30\,mg/dL.
    • Creatinine: Elevated levels greater than 1.5mg/dL1.5\,mg/dL.
  • Ketones: The presence of ketones is confirmed via urine testing (positive for ketones).

Medical Management: Fluids and Acidosis Reversal

  • Reversing Acidosis:
    • The primary method for reversing the acidotic state is the administration of a Regular Insulin drip.
    • Regular Insulin is added to a saline solution and infused intravenously at a slow, controlled rate.
  • Correction of Dehydration:
    • Fluid replacement is critical; patients may require between 6L6\,L and 10L10\,L of intravenous fluids (IVF) to replace the total volume lost.
    • Initial Fluid Protocol: Normal Saline Solution (0.9% sodium chloride0.9\%\text{ sodium chloride}) is typically administered initially at a rate of 500mL/hr500\,mL/hr to 1000mL/hr1000\,mL/hr for the first 22 to 33 hours.
    • Subsequent Fluid Administration: The decision to continue or adjust the fluid rate depends on the patient's electrolytes, vital signs (VSVS), and urinary output.
  • Restoration of Electrolytes:
    • Potassium (K+K^+) is of major concern during the treatment of DKA. As insulin is administered, potassium shifts from the extracellular fluid into the cells, which can lead to life-threatening hypokalemia.

Nursing Interventions and Clinical Monitoring

  • IV Site Assessment: The nurse must carefully monitor the IV site. Potassium is a vesicant, meaning it can be highly irritating to the veins; the nurse must ensure the IV line does not "blow" or infiltrate.
  • Vital Signs and Physical Assessment:
    • Respiratory Assessment: Use a stethoscope to check the lungs for crackles (indicating fluid overload), and monitor for shortness of breath (SOBSOB) or orthopnea.
    • Cardiac/Vascular Assessment: Monitor for distended neck veins and edema.
    • Neurological Assessment: Conduct regular mental status checks to evaluate the severity of altered mental status.
    • Weight: Monitor for sudden weight gain, which may indicate fluid retention.
  • Laboratory Monitoring:
    • Blood Glucose: Hourly monitoring of blood sugar levels is required.
    • Electrolytes and Kidney Function: Bloodwork should be drawn every 22 to 44 hours (q2hq2h to q4hq4h) to track sodium and potassium levels and to assess how the kidneys are functioning.
    • Intake & Output (I&OI \& O): Strict measurement of all fluid intake and urinary output is mandatory.

Patient Education and "Sick Day Rules"

  • Essential Monitoring: Patients must be taught how to accurately monitor their blood sugar levels and the importance of reducing risks for dehydration.
  • Sick Day Rules (The S.I.C.K. Acronym Management):
    • Insulin: Patients must continue to take their insulin even if they are feeling ill or are not eating normally.
    • Carbohydrates: Patients should attempt to replace carbohydrates every 22 to 44 hours (q2hq2h to q4hq4h) if they cannot eat regular meals.
    • Blood Sugar Checks: Frequency should increase to every 22 to 44 hours during illness.
    • Ketones: Test the urine for ketones every 22 to 44 hours or every time the patient uses the bathroom while sick.
  • When to Seek Medical Attention: Patients must be instructed to call their physician if they are persistently vomiting or if their symptoms do not improve.